Project Details
Description
Protocol #0113-CL-2001 entitled, "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/14 → 12/31/18 |
Funding
- ASTELLAS PHARMA US, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.